Denali Therapeutics: Vast Pipeline, First Approval Up Ahead
Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...
Biogen Inc. (BIIB) Stifel 2025 Virtual CNS Forum Conference (Transcript)
Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...
Pharmaceutical Technology3d
Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia
Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and ...
Biogen VP To Keynote 2025 Bioelectronic Medicine Forum In NYC
Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine ...
Le Lézard4d
SKYCLARYStm (omaveloxolone) Approval by Health Canada Ushers in a New Era for Friedreich's Ataxia Treatment in Canada
Biogen Canada Inc. is pleased to announce that Health Canada has approved SKYCLARYStm (omaveloxolone) for the treatment of Friedreich's ataxia (FA) in patients 16 years of age and older.2 This ...